StockData
Century Therapeutics, Inc. logo

Century Therapeutics, Inc. (IPSC) stock

IPSCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.38+0.01 (+0.73%)

Close on Nov 18, 2026Market cap $249.88MP/E –Yield –

Century Therapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Century Therapeutics

Century Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Century Therapeutics figures

See a number that looks wrong?